Login / Signup

Loss of FOCAD, operating via the SKI messenger RNA surveillance pathway, causes a pediatric syndrome with liver cirrhosis.

Ricardo Moreno TraspasTze Shin TeohPui-Mun WongMichael MaierCrystal Y ChiaKenneth LayNur Ain AliAustin LarsonFuad Al MutairiNouriya Abbas Al-SannaaEissa Ali FaqeihMajid AlfadhelHuma Arshad CheemaJuliette DupontStéphane BézieauBertrand IsidorDorrain Yanwen LowYulan WangGrace TanPoh San LaiHugues PiloquetMadeleine JoubertHülya KayseriliKimberly A KrippsShareef A NahasEric P WartchowMikako WarrenGandham SriLakshmi BhavaniMajed DasoukiRenata SandovalElisa CarvalhoLuiza RamosGilda PortaBin WuHarsha Prasada LashkariBadr AlSaleemRaeda M BaAbbadAnabela Natália Abreu FerrãoVasiliki KarageorgouNatalia Ordonez-HerreraSuliman KhanPeter BauerBenjamin CognéAida Maria Bertoli-AvellaMarie VincentKatta Mohan GirishaBruno Reversade
Published in: Nature genetics (2022)
Cirrhosis is usually a late-onset and life-threatening disease characterized by fibrotic scarring and inflammation that disrupts liver architecture and function. While it is typically the result of alcoholism or hepatitis viral infection in adults, its etiology in infants is much less understood. In this study, we report 14 children from ten unrelated families presenting with a syndromic form of pediatric liver cirrhosis. By genome/exome sequencing, we found recessive variants in FOCAD segregating with the disease. Zebrafish lacking focad phenocopied the human disease, revealing a signature of altered messenger RNA (mRNA) degradation processes in the liver. Using patient's primary cells and CRISPR-Cas9-mediated inactivation in human hepatic cell lines, we found that FOCAD deficiency compromises the SKI mRNA surveillance pathway by reducing the levels of the RNA helicase SKIC2 and its cofactor SKIC3. FOCAD knockout hepatocytes exhibited lowered albumin expression and signs of persistent injury accompanied by CCL2 overproduction. Our results reveal the importance of FOCAD in maintaining liver homeostasis and disclose a possible therapeutic intervention point via inhibition of the CCL2/CCR2 signaling axis.
Keyphrases